A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab

Published:2018-03 Issue:3 Volume:61 Page:306-313
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

Baxter Nancy N.,Fischer Hadas D.,Richardson Devon P.,Urbach David R.,Bell Chaim M.,Rochon Paula,Brade Anthony,Earle Craig C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference27 articles.

1. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.;Giantonio;J Clin Oncol,2007

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.;Hurwitz;N Engl J Med,2004

3. Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk.;Kabbinavar;Oncology,2008

4. Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer.;Abrams;J Natl Cancer Inst,2014

5. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.;Scappaticci;J Surg Oncol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of Bevacizumab on mucosal healing after dental extraction in patients undergoing cancer treatment in the central region of Algeria;2024-01-05

2. Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings;Surgical Oncology Clinics of North America;2023-12

3. The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study;Current Oncology;2023-07-06

4. Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study;European Journal of Surgical Oncology;2023-02

5. The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis;Journal of Gastrointestinal Oncology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3